MHRA to discuss innovation in Controlled Release and Combination Products

Top Quote SMi's Controlled Release conference, taking place on 18th - 19th April 2016 in London, will feature case studies provided by an array of global pharmaceutical companies. End Quote
  • (1888PressRelease) December 23, 2015 - SMi's 13th annual Controlled Release conference will provide the ideal platform to receive updates on the latest innovations to accelerate commercialisation, as well as developments in the regulatory landscape to ensure strict compliance. The two-day programme features case studies provided by GlaxoSmithKline, Ipsen, Novo Nordisk, MedImmune, AstraZeneca, Lundbeck, Merck, UCB Pharma, Critical Pharmaceuticals, Kashiv Pharma, Diurnal and more.

    Furthermore, SMi is delighted to announce that the MHRA's Pharmaceutical Assessor, Marion Westwood, will be delivering an opening address on Day One titled, 'Supporting innovation in controlled release and combination products'. Vital points covered include:
    The latest innovations surrounding controlled release
    Key regulatory updates from leading competent authorities talking specifically on grey areas such as the regulatory environment surrounding combination products
    Case study on work with OxSonics

    Speaker Panel includes:
    David Elder, Due Diligence Director, GlaxoSmithKline
    Andy Lewis, Director Novel Drug Delivery Technologies, Ipsen
    Sachin Mittal, Senior Principal Scientist, Merck
    Marianne Ashford, Principal Scientist Drug Targeting, AstraZeneca
    Sune Andersen, Principal Scientist, Novo Nordisk

    To view the full speaker line-up and conference programme, visit http://www.controlledrelease.co.uk/1888pressrelease

    Plus, don't miss two interactive post-conference workshops taking place on 20th April 2016 in London, UK:
    A: QbD/PAT Driven Controlled Release Design and Development | Led by Cristiana Campa, Head, Quality by Design Integration, GlaxoSmithKline and Jerome Mantanus, Senior Scientist QbD/PAT Drug Product Formulation, UCB Pharma

    B: Exploring Controlled Release Drug Delivery Methods | Led by Rene Holm, Senior Director, Lundbeck; Clive Wilson, Professor of Pharmaceutics, University of Strathclyde; Ijeoma Uchegbu, Scientific Secretary CRS, Chair in Pharmaceutical Nanoscience, University Of London and CEO, Nanometrics

    ###
space
space
  • FB Icon Twitter Icon In-Icon
Contact Information
  • Vinh Trinh
  • Smi Group
  • Unit 122/124 Great Guildford Business Square, 30 Great Guildford Street, London
  • SE1 0BS
  • Voice: 44 (0) 20 7827 6140
  • Visit our Site